PRIMORIGEN BIOSCIENCES, INC.
Synthetic cell culture matrix with modular ligand mixtures for hiPSC maintenance and directed differentiation, supplied as pre-coated tissue culture platforms
- Sector
- Biotech
- Total capital
- $535K
- Federal grants
- $535K
- 3 awards · 2015–2018
- Rank in peer group#12 of 20
- Private capital raised
- None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 1
- 5 pending · first 2016
- Rank in peer group#7 of 20
Capital timeline
Latest events
- Federal grantNASA · Phase I · Compact Precision Space IMU$125K
- Federal grantHealth and Human S · Phase I · A Novel Defined Xenobiotic Free Substrate that Mimics Natural Extracellular Matrix$180K
- Federal grantHealth and Human S · Phase I · A Novel Substrate to Amplify Growth Factor Impact on hPSC Differentiation$230K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 20 peers
Line = medianBiotech · Material
- Federal grantsBelow median
- Granted patents#7 · top 35%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
No founders are linked to this company yet.
Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.
Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026
Claim this profile to add your teamWhat it has protected
USPTO · 1 granted of 6- PendingCompositions And Methods For Differentiating Pluripotent Stem Cells Into Primitive Blood Cells And Uses ThereofUSPTOApplication 15250339
- GrantedCompositions And Methods For Differentiating Pluripotent Stem Cells Into Primitive Blood Cells And Uses ThereofUSPTOUS 9,428,732
- PendingFrameless Multiplexed MicroarraysUSPTOApplication 13826538
Show all 6 patent records
- Compositions And Methods For Differentiating Pluripotent Stem Cells Into Primitive Blood Cells And Uses ThereofDec 22, 2016 · Application 15250339Pending
- Compositions And Methods For Differentiating Pluripotent Stem Cells Into Primitive Blood Cells And Uses ThereofAug 30, 2016 · US 9,428,732Granted
- Frameless Multiplexed MicroarraysAug 8, 2013 · Application 13826538Pending
- Compositions And Methods For Differentiating Pluripotent Stem Cells Into Primitive Blood Cells And Uses ThereofApplication PCTUS2012068003Pending
- Affinity Measurements Using Frameless Multiplexed MicroarraysApplication PCTUS2008081587Pending
- Frameless Multiplexed MicroarraysApplication PCTUS2008076871Pending
Related companies, and why
- LUCIOLE PHARMACEUTICALS, INC.Similar federal contract value in Biotech · null in contracts
- HEARTLAND VACCINES, LLCSimilar federal contract value in Biotech · null in contracts
- GLYCO DISCOVERIES, INCSimilar federal contract value in Biotech · null in contracts
- Grace Bio-Labs, Inc.Similar federal contract value in Biotech · null in contracts
- TARGUT BIOTECHNOLOGIES INC.Similar federal contract value in Biotech · null in contracts
- SignalRx Pharmaceuticals Inc.Similar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .